|
|
|
2001 Volume No 1 -
pages 66-81
|
Title: Animal models of osteoporosis - necessity and
limitations
|
|
Authors: A. Simon Turner
|
|
Address: Department of Clinical Sciences, Colorado
State University, Ft. Collins, CO 80523, USA
|
|
E-mail: sturner at lamar.colostate.edu
|
|
Key Words: Osteoporosis, osteopenia, animal models,
bone mineral density, ovariectomized sheep, bone metabolism,
hormonal therapy, selective estrogen receptor modulatorss,
implants, ceramics, vertebroplasty.
|
|
Publication date: 22th June 2001
|
|
Abstract: There is a great need to further characterise
the available animal models for postmenopausal osteoporosis,
for the understanding of the pathogenesis of the disease,
investigation of new therapies (e.g. selective estrogen receptor
modulators (SERMs)) and evaluation of prosthetic devices in
osteoporotic bone. Animal models that have been used in the
past include non-human primates, dogs, cats, rodents, rabbits,
guinea pigs and minipigs, all of which have advantages and
disadvantages. Sheep are a promising model for various reasons:
they are docile, easy to handle and house, relatively inexpensive,
available in large numbers, spontaneously ovulate, and the
sheep's bones are large enough to evaluate orthopaedic implants.
Most animal models have used females and osteoporosis in the
male has been largely ignored. Recently, interest in development
of appropriate prosthetic devices which would stimulate osseointegration
into osteoporotic, appendicular, axial and mandibular bone
has intensified. Augmentation of osteopenic lumbar vertebrae
with bioactive ceramics (vertebroplasty) is another area that
will require testing in the appropriate animal model. Using
experimental animal models for the study of these different
facets of osteoporosis minimizes some of the difficulties
associated with studying the disease in humans, namely time
and behavioral variability among test subjects. New experimental
drug therapies and orthopaedic implants can potentially be
tested on large numbers of animals subjected to a level of
experimental control impossible in human clinical research.
|
|
Article download: Pages
66-81 (PDF file)
|
|
Acrobat Reader:

|
To read this article you will need to install Adobe
Acrobat Reader on your computer. Should you experience
any difficulty in reading the PDF file we suggest that
you save the file to your computer BEFORE opening it
from Adobe Acrobat.
|
|
|
Comments received (Online discussion on papers more
than 1 year old are closed)
|
|
| |